EORTC Cancer in the Elderly Task Force investigates appropriate treatment for elderly patients

November 25, 2013

As we age, we experience a progressive decline in many of our bodily functions. This decline can vary greatly from individual to individual. One 75 year old might still be very active and participate in strenuous physical activities, while another might require considerable assistance just to perform simple everyday tasks. Aging is variable. It is a highly individualized process that is influenced by a number of genetic, developmental, and environmental factors.

Many things, not simply chronological age, contribute to treatment tolerance and outcome in older patients with cancer, and these present challenges when determining appropriate treatment. Recently, though, members of the EORTC Cancer in the Elderly Task Force, in a paper published in the Journal of Geriatric Oncology, evaluated the physiological reserves of with cancer and described the most relevant biomarkers that might potentially serve to indicate their functional biological age.

Dr. Hans Wildiers of the University Hospitals Leuven, Chair of the Cancer in the Elderly Task Force, and co-author of this study, says, "The incidence of most malignant diseases increases with age. Studies have shown that slightly more than half of all newly diagnosed cancer cases and more than two thirds of cancer-related deaths occur in patients 65 years or older. So, we expect the number of older patients with will increase as the population ages. Doctors will increasingly need to make treatment decisions for , and to make effective decisions, we will need better biological markers of aging."

The EORTC Cancer in the Elderly Task Force study provides a guideline on integrating several potential biomarkers of aging: inflammatory markers, telomere length and telomerase activity, genetic predisposition for longevity, of aging related genes in peripheral blood mononuclear cell, immunosenescence, lymphocyte senescence p16INK4a expression in T lymphocytes, and plasma microRNA expression profile.

They point out that comprehensive geriatric assessment can provide information on the general health status of individuals, but that it is far from perfect as a prognostic or predictive tool for individual patients. Alternatively, biological changes in certain tissues which are the result of adaptive alterations due to past exposures as well as the can help to assess aging.

Explore further: EORTC study opens for elderly patients with HER-2 positive metastatic breast cancer

Related Stories

Linking risk factors and disease origins in breast cancer

November 20, 2013

Researchers from the Geisel School of Medicine at Dartmouth have found that epigenetic changes to DNA are associated with aging in disease-free breast tissues and are further altered in breast tumors. Epigenetic changes describe ...

Tipping the balance between senescence and proliferation

November 15, 2013

An arrest in cell proliferation, also referred to as cellular senescence, occurs as a natural result of aging and in response to cellular stress. Senescent cells accumulate with age and are associated with many aging phenotypes, ...

Population aging crisis may have been overestimated

November 13, 2013

(HealthDay)—Use of an alternative measure for assessing the number of dependent older people suggests that the population aging crisis may have been overestimated, according to an analysis published online Nov. 12 in BMJ.

Recommended for you

Ancient stress response provides clues to cancer resistance

April 25, 2017

Cancer is often able to craftily outwit the best techniques modern medicine has developed to treat it. In an attempt to understand and combat cancer's vaunted prowess, an unusual collaboration between physicists and a leading ...

Studying a catalyst for blood cancers

April 25, 2017

Imagine this scenario on a highway: A driver starts to make a sudden lane change but realizes his mistake and quickly veers back, too late. Other motorists have already reacted and, in some cases, collide. Meanwhile, the ...

Savior of T-cells may be enemy of liver immune cells

April 24, 2017

Researchers at Houston Methodist demonstrated that a surface protein called OX40, responsible for keeping one type of immune system cell alive, can trigger the death of liver immune cells, in turn starting a chain reaction ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.